Patient Resources

Get Healthy!

  • Posted April 9, 2025

Experimental Drug Shows Promise in Slowing Disability from Multiple Sclerosis

Results of a phase 3 clinical trial show an experimental drug called tolebrutinib can delay disability in patients with non-relapsing secondary progressive multiple sclerosis.

Health News is provided as a service to Juro's Pharmacy Health & Wellness site users by HealthDay. Juro's Pharmacy Health & Wellness nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2025 HealthDay All Rights Reserved.

Share

Tags